Ferric Pyrophosphate Citrate Patent Expiration

Ferric Pyrophosphate Citrate is Used for treating patients with iron deficiency and in need of iron replacement therapy. It was first introduced by Rockwell Medical Inc in its drug Triferic on Jan 23, 2015. Another drug containing Ferric Pyrophosphate Citrate is Triferic Avnu.


Ferric Pyrophosphate Citrate Patents

Given below is the list of patents protecting Ferric Pyrophosphate Citrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Triferic US7816404 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions Apr 17, 2029 Rockwell Medical Inc
Triferic Avnu US7816404 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions Apr 17, 2029 Rockwell Medical Inc
Triferic US7857977 Packaging of ferric pyrophosphate for dialysis Sep 08, 2027 Rockwell Medical Inc
Triferic US6689275 Method and pharmaceutical composition for replacing iron losses in dialysis patients Dec 31, 2016

(Expired)

Rockwell Medical Inc
Triferic US6779468 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients Dec 31, 2016

(Expired)

Rockwell Medical Inc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ferric Pyrophosphate Citrate's patents.

Given below is the list recent legal activities going on the following patents of Ferric Pyrophosphate Citrate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Yr, Small Entity 19 May, 2022 US7857977
Payment of Maintenance Fee, 12th Yr, Small Entity 22 Mar, 2022 US7816404
Email Notification 16 Jan, 2019 US7816404
Correspondence Address Change 15 Jan, 2019 US7816404
Change in Power of Attorney (May Include Associate POA) 15 Jan, 2019 US7816404
Payment of Maintenance Fee, 8th Yr, Small Entity 14 Jun, 2018 US7857977
Payment of Maintenance Fee, 8th Yr, Small Entity 05 Apr, 2018 US7816404
Change in Power of Attorney (May Include Associate POA) 17 Jan, 2014 US7857977
Change in Power of Attorney (May Include Associate POA) 17 Jan, 2014 US7816404
Correspondence Address Change 16 Jan, 2014 US7857977


Ferric Pyrophosphate Citrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List